Why RAPP fell 23.6% on Oct 28 2026: priced financing
RAPP-23.6%on Wed Oct 28 2026
Rapport Therapeutics, Inc. Common Stock was down 23.6% on the day at $21.05, ranked #3 on 58.1× its usual five-minute volume, when TapeRank recorded this drop at 08:43 ET during the pre-market session.
THE DAY ON THE LIST · 1 EVENT
- 08:43 ETMOVER · PRE-MARKET
$21.05 · ▼ 23.6% ON THE DAY · 58.1× 5M RVOL · RANK #3
JUSTIFIEDCONFIDENCE5/5RAPP is down 19.4% after pricing roughly $175 million of stock, warrants, and a $150 million convertible-notes offering at $21 per share-equivalent. The financing creates immediate dilution and pricing pressure, making the decline broadly consistent with the catalyst.
WHYA 19.4% pre-market drop is proportionate to a large equity-and-convertible financing priced below the prior $25.33 close, with additional issuance risk.ANALYZED 09:17 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNATHE ROW AND SESSION LEVELS AT 08:43 ET
LAST21.05DAY▼ 23.6%5 MIN▲ 1.18%5M RVOL58.1×5M $VOL$620KFLOAT*48.0MRANK#3SESSIONPRE-MARKETVWAP21.23HOD22.81LOD20.72OR HIGH—OR LOW—PREV CLOSE27.54PM HIGH22.81PM LOW20.72GAP▼ 24.24% (indicated)* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
— MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO
THE SESSION
- 09:30 ETOpened at $22.55, -18.1% on the previous close of $27.54
- 09:39 ETRegular-session high, $23.94
- 15:29 ETRegular-session low, $22.06
- 15:59 ETLast trade of the regular session, $22.49, -18.3% on the previous close of $27.54
- Volume: 5.2M shares in regular hours, 369K before the open
RAPP opened at $22.55 after TapeRank had recorded it at $21.05 premarket, then briefly rose to a $23.94 high before reversing to a $22.06 low and ending the regular session at $22.49, down 18.3% from the previous close. TapeRank’s read tied the move to the company’s priced financing: roughly $175 million of stock and warrants alongside $150 million of convertible notes, with the stock offering priced at $21 per share-equivalent, creating dilution and pricing pressure. There were no halts during the session.
WRITTEN WED OCT 28 2026 16:00 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE
FILINGS AND NEWS · 24H BEFORE THE MOVE
- 06:08 ETRapport Therapeutics Prices Separate Offerings Of ~$175M Of Stock At $21.00/Share, Warrants To Purchase Up To ~$25M Of Stock At $20.999 Per Pre-Funded Warrant, And $150M Of 2.25% Convertible Senior Notes Due 2032Benzinga
- 03:01 ETRapport Therapeutics (RAPP) Shares Sink 20% After HoursBenzinga
- TUE 16:56 ETRapp Therapeutics Files For Offering Of Common Stock; Size Not DisclosedBenzinga
- TUE 16:55 ET424B5 — Prospectus supplement — offering pricedSEC 424B5
- TUE 16:52 ET424B5 — Prospectus supplement — offering pricedSEC 424B5
- TUE 16:35 ETRapport Therapeutics Commences Separate Underwritten Public Offerings Of $200M Of Shares And $150M Aggregate Principal Amount Of Convertible Senior Notes Due 2032Benzinga
On the tape right now
WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY
Open the full list